Gardner Lewis Asset Management’s Immunomedics Inc IMMU Stock Holding History

Gardner Lewis Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-307,000	Closed	-$26.1M	–	83
2020 Q3	$26.1M	Buy	+307,000	New	+$15.5M	4.73%	5

Gardner Lewis Asset Management's IMMU Position: Q4 2020 in Review

Gardner Lewis Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 307,000 shares — an estimated $26.1M sold.

Gardner Lewis Asset Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $26.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Gardner Lewis Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Gardner Lewis Asset Management sold 307,000 Immunomedics Inc shares in Q4 2020, an estimated $26.1M.
Gardner Lewis Asset Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Gardner Lewis Asset Management's Immunomedics Inc position peaked at $26.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.